Novavax Inc
SWB:NVV1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novavax Inc
SWB:NVV1
|
US |
|
I
|
Inter Cars SA
WSE:CAR
|
PL |
|
T
|
Teva Pharmaceutical Industries Ltd
SWB:TEV
|
IL |
|
Pangaea Logistics Solutions Ltd
NASDAQ:PANL
|
US |
|
G
|
General Mills Inc
F:GRM
|
US |
|
Keyence Corp
OTC:KYCCF
|
JP |
|
Advance Auto Parts Inc
NYSE:AAP
|
US |
Wall St Price Targets
NVV1 Price Targets Summary
Novavax Inc
According to Wall Street analysts, the average 1-year price target for NVV1 is 14.12 EUR with a low forecast of 6.12 EUR and a high forecast of 22.71 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NVV1's stock price target?
Price Target
14.12
EUR
According to Wall Street analysts, the average 1-year price target for NVV1 is 14.12 EUR with a low forecast of 6.12 EUR and a high forecast of 22.71 EUR.
What is the Revenue forecast for Novavax Inc?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 0%.
What is the Gross Profit forecast for Novavax Inc?
Projected CAGR
-32%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 46%. The projected CAGR for the next 3 years is -32%.
What is the Operating Income forecast for Novavax Inc?
Projected CAGR
2%
The compound annual growth rate for Operating Income over the next 8 years is 2%.
What is the Pre-Tax Income forecast for Novavax Inc?
Projected CAGR
-43%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -43%.
What is the Net Income forecast for Novavax Inc?
Projected CAGR
-21%
The compound annual growth rate for Net Income over the next 7 years is -21%.